(PDF) Cutting Edge: B Cells Expressing Cyclic Citrullinated

Cutting Edge: B Cells Expressing Cyclic Citrullinated Peptide–Specific Antigen Receptor Are Tolerized in Normal Conditions

Journal of Immunology - United States

doi 10.4049/jimmunol.1800826

Full Text

Abstract

Available in full text

Categories

Date

November 12, 2018

Authors

Hisakata Yamada

Tatsuhiko Ozawa

Yasuharu Nakashima

Atsushi Muraguchi

Yasunobu Yoshikai

Publisher

The American Association of Immunologists

Related search

Genetically Engineered T Cells Expressing a HER2-specific Chimeric Receptor Mediate Antigen-Specific Tumor Regression

Cancer Gene Therapy

Cancer Research

Molecular Medicine

Molecular Biology

English

Cutting Edge: Antigen-Specific Thymocyte Feedback Regulates Homeostatic Thymic Conventional Dendritic Cell Maturation

Journal of Immunology

English

Anti-Citrullinated Cyclic Peptide Antibody and Functional Disability Are Associated With Poor Sleep Quality in Rheumatoid Arthritis

Archives of Rheumatology

English

Anti-Cyclic Citrullinated Peptide Antibodies in Patients With Primary Sjogren's Syndrome

Annals of the Rheumatic Diseases

Molecular Biology

English

AB0313 Cardiovascular Risk, Biologics and Anti-Cyclic Citrullinated Peptide Positivity in Rheumatoid Arthritis

English

Clostridium Butyricum in Combination With Specific Immunotherapy Converts Antigen-Specific B Cells to Regulatory B Cells in Asthmatic Patients

Scientific Reports

Multidisciplinary

English

Cutting Edge: Identification of Marginal Reticular Cells as Phagocytes of Apoptotic B Cells in Germinal Centers

Journal of Immunology

English

Impaired Tumor Antigen Processing by Immunoproteasome-Expressing CD40-activated B Cells and Dendritic Cells

Cancer Immunology, Immunotherapy

Cancer Research

English

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer

Frontiers in Immunology

English